News Image

BCLI Update - Progress Supports Our 10x Plus Value Range Potential

Provided By PR Newswire

Last update: Jul 24, 2024

ACF Equity Research 

FROM ACF EQUITY RESEARCH HEALTHCARE TEAM

LONDON, July 24, 2024 /PRNewswire/ -- 

NASDAQ: BCLI

READ ACF EQUITY RESEARCH'S UPDATE NOTE HERE 

Read more at prnewswire.com

BRAINSTORM CELL THERAPEUTICS

NASDAQ:BCLI (2/21/2025, 8:02:56 PM)

1.73

-0.07 (-3.89%)



Find more stocks in the Stock Screener

Follow ChartMill for more